Literature DB >> 17473828

Estimates of heritable and environmental components of familial breast cancer using family history information.

E Couto1, K Hemminki.   

Abstract

Using the Swedish Family-Cancer Database, the increased risk of breast cancer in women with relatives with the disease did not vary with paternal/maternal lineage. Familial breast cancer heritable component was 73% and the environmental proportion 27%. Familial aggregation of breast cancer in women below age 51 years is mainly due to heritable causes.

Entities:  

Mesh:

Year:  2007        PMID: 17473828      PMCID: PMC2359918          DOI: 10.1038/sj.bjc.6603753

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


Although having a mother or sister diagnosed with breast cancer is known to increase a woman's risk of the disease (Collaborative Group on Hormonal Factors in Breast Cancer, 2001), the mechanisms underlying this association remain unclear. A family represents a group of individual sharing a common environment and genes. Hence, the mechanisms leading to this higher risk of breast cancer could be environmental, genetic, or a combination of the two. Twin and other family studies have consistently shown a familial aggregation of female breast cancer (Lichtenstein ; Collaborative Group on Hormonal Factors in Breast Cancer, 2001; Hemminki and Granstrom, 2003; Amundadottir ; Kerber and O'Brien, 2005; Baker ). The familial risk of about 2.0 among first-degree relatives is so high that a substantial part of it must be caused by heritable factors (Hopper and Carlin, 1992; Lorenzo and Hemminki, 2005). One estimate suggests that heritable factors contribute to 27% of the total risk of breast cancer, and environmental factors to 73% (Lichtenstein ). However, no corresponding studies have estimated these components in familial breast cancer. While, these proportions have mostly been measured using twin data, we use instead first- and second-degree familial relationships. As environmental sharing between second-degree relatives is probably low, the breast cancer risk associated with having affected second-degree relatives is assumed to be due to heritable causes. Breast cancers with a possible genetic cause have mainly been diagnosed at young ages (Hall ; King ), implying that the heritable component varies with age. It is unknown whether breast cancer risk associated with family history differs according to the side of the family of the affected relative. Probably due to lack of reliable data, few studies have investigated this possible difference in risk (Macklin, 1959). However, such studies would clarify breast cancer inheritance pathways. This population-based study investigated breast cancer risk among women having first- and second-degree relatives with the disease, in order to estimate the heritable and environmental components of familial breast cancer, according to women's age; risk was also examined according to paternal/maternal lineage.

MATERIALS AND METHODS

The Swedish Family-Cancer Database was described in detail previously (Hemminki ). This Database was created by linking information from the national multigeneration register, censuses, cancer registries and national deaths notification using the national 10-digit personal number. Histories of cancer among mothers, sisters, grandmothers and aunts were extracted from the multigeneration register. Information on both maternal and paternal grandmothers was available for 1 550 374 women; 868 of these, born between 1952 and 1979, had been diagnosed with invasive breast cancer (with age at diagnosis of 50 years or below). Each case was matched on year of birth and geographical region to four women free of invasive and in situ breast cancer and alive at the date of the case's diagnosis. Odds ratios (ORs) for invasive breast cancer associated with having an affected relative were estimated, using conditional logistic regression. Analyses were adjusted for mother's and father's year of birth, number of maternal and paternal aunts, and number of sisters. The analyses of familial breast cancer risk associated with second-degree family history according to paternal/maternal lineage were adjusted for the above variables excluding number of sisters. Differences between ORs were evaluated using standard χ2 heterogeneity tests. These ORs were used to estimate heritable and environmental components of familial breast cancer. Owing to low environmental sharing among second-degree relatives, the risk associated with having affected second-degree relatives was assumed to be due to heritable causes. Hence, assuming a 50% gene sharing between first- and second-degree relatives, we concluded that the excess risk associated with first-degree family history should be equal to twice the excess risk associated with second-degree family history. This excess risk was considered as being due to heritable causes. If it was lower than the excess risk evaluated through conditional logistic regression, the difference was assumed to be due to environmental causes.

RESULTS

Women with a first- and second-degree relative with breast cancer had a higher risk of contracting the disease than women without such a family history (Figure 1). This risk was higher when the affected relative is a mother and/or a sister(s) compared to a grandmother and/or an aunt(s). In women of all ages, the ORs for breast cancer associated with first- and second-degree family history were 2.86 (95% CI: 2.15–3.82) and 1.68 (1.38–2.03), respectively. Those risks were higher when women were of a younger age. Breast cancer risk did not vary with paternal/maternal lineage, the OR being 1.64 (1.25–2.14) and 1.68 (1.30–2.17) when the affected relative was on the mother's and father's side of the family, respectively (Figure 1).
Figure 1

OR for breast cancer associated with family history of the disease.

Considering the breast cancer risk associated with having an affected second-degree relative as a correct estimate of familial breast cancer risk due to heritable causes, heritable and environmental components of breast cancer were estimated using the ORs presented in Figure 1 (see Table 1). Considering all women, familial breast cancers were 73% heritable and 26% environmental. The heritable component was 96 and 66% in women aged less than 40 and 40–50 years, respectively.
Table 1

Heritable and environmental components of familial breast cancer according to the ORs for breast cancer associated with first- and second-degree FH by women's age

OR for breast cancer associated with second-degree FH Corresponding excess risk Corresponding ORs for breast cancer associated with first-degree FHa Observed ORs for breast cancer associated with first-degree FH Heritable component (%)b, c Environmental component (%) d
All ages
 1.680.681.36 (0.68 × 2)1.861.36 (73%)0.50 (1.86–1.36) (27%)
      
Women aged less than 40 years
 1.990.991.98 (0.99 × 2)2.061.98 (96%)0.08 (2.06–1.98) (4%)
      
Women aged 40–50 years
 1.600.601.20 (0.60 × 2)1.831.20 (66%)0.63 (1.83–1.20) (34%)
      

FH=family history; OR=odds ratio.

These estimates were obtained using the excess risk corresponding to the ORs for breast cancer associated with second-degree family history.

The heritable component is assumed to be equal to the third column.

The percentages were obtained dividing the third by the fourth column.

The percentage was obtained by substracting the percentage of the fifth column to 100.

DISCUSSION

Women with first- and second-degree relatives with breast cancer have a higher risk of the disease themselves. This risk is higher when the affected relative was a mother or a sister(s) compared to a grandmother or an aunt(s), as found in a meta-analysis of 74 studies (Pharoah ). Family history of breast cancer was extracted from national registries and did not rely on reporting of affected relatives as in most studies. The quality of reporting was found to worsen with increasingly distant relatives (Ziogas and Anton-Culver, 2003), indicating possible unreliability of the data in such studies. Few studies have investigated whether breast cancer risk varies according to paternal/maternal lineage (Macklin, 1959). In the present study, the risk of breast cancer associated with having affected second-degree relatives did not vary according to paternal/maternal lineage, which is consistent with the failure to identify sex-linked genes in breast cancer. This report uses a novel method to estimate heritable and environmental components of a disease. Although these proportions have mostly been measured using twin data, we used first- and second-degree family history. Overall, familial breast cancer was found to be 73% heritable and 26% environmental, suggesting that familial aggregation in young breast cancers is mainly due to heritable factors. Previous studies have found similar results (Hopper and Carlin, 1992; Hemminki and Granstrom, 2003). The heritable component of familial breast cancers increased with decreasing women's age, with 96 and 66% of familial breast cancers in women aged below 40 and 40–50 years, respectively. Factors explaining breast cancer familial aggregation might differ according to age. Participants included in the present report were born between 1952 and 1979, with age at diagnosis ranging between 16 and 50 years old, and different estimates of heritable and environmental components of familial breast cancer might be observed in older cases. The Swedish Family-Cancer Database includes information on most of the Swedish population, providing results, which are generalisable to a population of a similar age to the one discussed. The results presented here suggest that familial aggregation in young breast cancers is mainly due to heritable causes.
  14 in total

1.  Family history and the risk of breast cancer: a systematic review and meta-analysis.

Authors:  P D Pharoah; N E Day; S Duffy; D F Easton; B A Ponder
Journal:  Int J Cancer       Date:  1997-05-29       Impact factor: 7.396

2.  A cohort study of cancer risk in relation to family histories of cancer in the Utah population database.

Authors:  Richard A Kerber; Elizabeth O'Brien
Journal:  Cancer       Date:  2005-05-01       Impact factor: 6.860

3.  Inherited breast and ovarian cancer. What are the risks? What are the choices?

Authors:  M C King; S Rowell; S M Love
Journal:  JAMA       Date:  1993-04-21       Impact factor: 56.272

4.  Genetic susceptibility to prostate, breast, and colorectal cancer among Nordic twins.

Authors:  Stuart G Baker; Paul Lichtenstein; Jaakko Kaprio; Niels Holm
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

5.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

Authors:  P Lichtenstein; N V Holm; P K Verkasalo; A Iliadou; J Kaprio; M Koskenvuo; E Pukkala; A Skytthe; K Hemminki
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

Review 6.  Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.

Authors: 
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

7.  The nation-wide Swedish family-cancer database--updated structure and familial rates.

Authors:  K Hemminki; X Li; K Plna; C Granström; P Vaittinen
Journal:  Acta Oncol       Date:  2001       Impact factor: 4.089

8.  Comparison of the number of breast-cancer deaths observed in relatives of breast-cancer patients, and the number expected on the basis of mortality rates.

Authors:  M T MACKLIN
Journal:  J Natl Cancer Inst       Date:  1959-05       Impact factor: 13.506

9.  Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale.

Authors:  J L Hopper; J B Carlin
Journal:  Am J Epidemiol       Date:  1992-11-01       Impact factor: 4.897

10.  Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family.

Authors:  Laufey T Amundadottir; Sverrir Thorvaldsson; Daniel F Gudbjartsson; Patrick Sulem; Kristleifur Kristjansson; Sigurdur Arnason; Jeffrey R Gulcher; Johannes Bjornsson; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  PLoS Med       Date:  2004-12-28       Impact factor: 11.069

View more
  6 in total

1.  Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer.

Authors:  Beata Bielinska; Pawel Gaj; Anna Kluska; Dorota Nowakowska; Aneta Balabas; Michalina Dabrowska; Anna Niwinska; Jakub Gruchota; Renata Zub; Elzbieta Skasko; Jan Steffen; Jerzy Ostrowski; Janusz A Siedlecki
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

2.  Bias in the reporting of family history: implications for clinical care.

Authors:  Elissa M Ozanne; Adrienne O'Connell; Colleen Bouzan; Phil Bosinoff; Taryn Rourke; Dana Dowd; Brian Drohan; Fred Millham; Pat Griffin; Elkan F Halpern; Alan Semine; Kevin S Hughes
Journal:  J Genet Couns       Date:  2012-01-12       Impact factor: 2.537

3.  Breast and ovarian cancer: the forgotten paternal contribution.

Authors:  Jeanna M McCuaig; Celia M T Greenwood; Cheryl Shuman; David Chitayat; K Joan Murphy; Barry Rosen; Susan Randall Armel
Journal:  J Genet Couns       Date:  2011-04-19       Impact factor: 2.537

4.  Components of family history associated with women's disease perceptions for cancer: a report from the Family Healthware™ Impact Trial.

Authors:  Wendy S Rubinstein; Suzanne M O'neill; Nan Rothrock; Erin J Starzyk; Jennifer L Beaumont; Louise S Acheson; Catharine Wang; Robert Gramling; James M Galliher; Mack T Ruffin
Journal:  Genet Med       Date:  2011-01       Impact factor: 8.822

5.  Asymmetry in family history implicates nonstandard genetic mechanisms: application to the genetics of breast cancer.

Authors:  Clarice R Weinberg; Min Shi; Lisa A DeRoo; Jack A Taylor; Dale P Sandler; David M Umbach
Journal:  PLoS Genet       Date:  2014-03-20       Impact factor: 5.917

Review 6.  Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese Population.

Authors:  Lu Shen; Shizhen Zhang; Kaiyue Wang; Xiaochen Wang
Journal:  Front Oncol       Date:  2021-12-01       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.